Efficacy and safety of elobixibat in hemodialysis patients with chronic constipation: a retrospective study
Abstract Background Hemodialysis patients are likely to develop constipation as a complication due to food and fluid restrictions. Elobixibat is a new laxative that inhibits the ileal bile acid transporter expressed in the terminal ileum, suppresses bile acid reabsorption, increases the amount of bi...
Main Authors: | Takefumi Shono, Hiroyuki Hyakutake |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-04-01
|
Series: | Renal Replacement Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s41100-020-00267-y |
Similar Items
-
Elobixibat alleviates chronic constipation in hemodialysis patients: a questionnaire-based study
by: Daigo Kamei, et al.
Published: (2020-01-01) -
Efficacy and Safety of Elobixibat in Elderly Patients with Chronic Constipation: A Single-center, Observational Study
by: Tatsuya Abe, et al.
Published: (2020-07-01) -
Comparative profiles of lubiprostone, linaclotide, and elobixibat for chronic constipation: a systematic literature review with meta-analysis and number needed to treat/harm
by: Satish S. Rao, et al.
Published: (2024-01-01) -
Effects of Elobixibat on Constipation and Lipid Metabolism in Patients With Moderate to End-Stage Chronic Kidney Disease
by: Momoko Matsuyama, et al.
Published: (2022-01-01) -
Treatment of Chronic Constipation using Elobixibat in a Real-World Setting: A Retrospective Cohort Study using an Electronic Medical Records Database in Japan
by: Hisanori Masaki, MS, et al.
Published: (2023-01-01)